Head-to-Head

Boston Scientific Corp. vs. InfuSystem Holdings, Inc.

BSX

Boston Scientific Corp.

$49.30 +3.27%

VS INFU

InfuSystem Holdings, Inc.

$12.49 +5.22%

Boston Scientific Corp. (BSX) comes out ahead, leading on 7 of 9 compared factors.

Size & Scale

BSXINFU
Market Cap $71.45 billion $248.77 million
Revenue (TTM) $21.00 billion $143.34 million
Net Income (TTM) $3.67 billion $8.54 million

BSX leads on 3 of 3 size & scale factors.

Valuation

BSXINFU
P/E Ratio 19.96 31.22
Price / Book 2.84 4.21
Price / Sales 3.40 1.74

BSX leads on 2 of 3 valuation factors.

Profitability

BSXINFU
Net Margin 17.47% 5.96%
Return on Equity 14.58% 14.44%

BSX leads on 2 of 2 profitability factors.

Risk & Sentiment

BSXINFU
Short Interest 0.70% 0.02%

INFU leads on 1 of 1 risk & sentiment factors.

Dig deeper: BSX overview, BSX financials, INFU overview, INFU financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.